Alternative Substrates in the Critically Ill Subject

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions
Critical Illness
Interventions
OTHER

Modular ketogenic feed

Dietician prescribed, and consisting of Betaquik® (from Vitaflo, Nutritional company) to provide medium chain triglycerides), Renapro Shot® (protein), Maxijul® (carbohydrate) and multivitamins according to nutritional need (energy and protein requirements) based on clinical status of the participant. Ketogenic feed to be given continuously via nasogastric tube for 10 days

OTHER

Standard feed

Standard Enteral feed. Dietician prescribed based on clinical status of the participant, as per individual Trust protocols. Standard feed to be given continuously via nasogastric tube for 10 days

Trial Locations (2)

BS2 8HW

Bristol Royal Infirmary, Bristol

E1 1BB

Royal London Hospital, London

All Listed Sponsors
collaborator

Bristol Royal Infirmary

UNKNOWN

collaborator

Institute of Child Health

OTHER

lead

Barts & The London NHS Trust

OTHER

NCT04101071 - Alternative Substrates in the Critically Ill Subject | Biotech Hunter | Biotech Hunter